GEN - Genetic Engineering and Biotechnology News

Astellas Takes Aim at XLMTM Again, Now with MyoAAV Capsid-Based Gene Therapy

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

U.S. GoldMining Identifies New Au-Cu Porphyry Targets from 2025 Exploration Program at the Whistler Gold-Copper Project, Alaska

CNW/ - U.S. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce the initial results of the 2025 ...

Data retrieval and embeddings enhancements from MongoDB set the stage for a year of specialized AI

Data retrieval and embeddings enhancements from MongoDB set the stage for a year of specialized AI - SiliconANGLE ...

ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of its Genetic Medicine Technology and Manufacturing Business

ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...

RTP’s AskBio wants to make $4 billion price tag look like a bargain

It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
TMCnet

Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

NorthWest Reports Exploration Target Drill Results Highlighting Expansion Potential at Andesite Breccia

NorthWest Copper Corp. (“NorthWest” or the “Company”) (TSX-V: NWST) reports the final drill results from its 2025 exploration ...

GoldMining Inc.: U.S. GoldMining Identifies New Au-Cu Porphyry Targets from 2025 Exploration Program at the Whistler Gold-Copper Project, Alaska

ANCHORAGE, Alaska, Jan. 20, 2026 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce the initial results of the 2025 exploration ...
The American Bazaar

Cybersecurity firm Cyble uncovers android banking malware targeting Iranian users

Cyble uncovers deVixor Android banking trojan targeting Iranian users via phishing, ransomware, SMS theft, and credential ...

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...

Krystal Biotech: Beyond VYJUVEK Commercialization

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.
Cyber Defense Magazine

From Clips To Clones

Social media has long been a valuable source of personally identifiable information (PII) for cybercriminals, but the rise of ...